Interleukin-10 is expressed in HepG2.2.15 cells and regulated by STAT1 pathway

J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):625. doi: 10.1007/s11596-011-0572-3. Epub 2011 Oct 25.

Abstract

This study investigated the expression profiles of IL-10 gene in three human hepatoma cell lines including Huh7, HepG2, and HepG2 transfected with a plasmid containing hepatitis B virus (HBV) named HepG2.2.15. RT-PCR analysis demonstrated that IL-10 message RNA was absent in HepG2 and Huh7 cells, whereas it was present in HepG2.2.15 cells, which was consistent with ELISA result. Furthermore, except for lamivudine other antiviral treatments did not significantly decrease the HBV DNA level in HepG2.2.15 cells, while they had different effects on the expression of IL-10 protein, although stimulation by LPS had no significant effect. In addition, except for poly(I:C), the other treatments decreased the expression of IL-10 protein to different degrees, but had no significant effects on the expression of NF-κB and MyD88. Meanwhile, all treatments we used had effect on the expression of STAT1. In conclusion, IL-10 was expressed in HepG2.2.15 cells and STAT1 pathway might be involved in the regulation of IL-10 expression in HepG2.2.15 cells, but it was not the sole pathway, the exact mechanism warrants further study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Hep G2 Cells
  • Hepatitis B virus
  • Humans
  • Interleukin-10 / genetics
  • Interleukin-10 / metabolism*
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • STAT1 Transcription Factor / metabolism*
  • STAT1 Transcription Factor / physiology
  • Signal Transduction

Substances

  • IL10 protein, human
  • RNA, Messenger
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Interleukin-10